1 UMMC Nursing Newsletter September 2012 Volume 1, Issue 8 IV Infusion Pump Update Background/Situation: The UMMC contract with Alaris/Carefusion for IV pumps and disposables has expired. UMMC is in need of additional pumps to accommodate: (1) increased beds in new Shock Trauma tower, and (2) a general increase in acuity of patients throughout the Medical Center requiring multiple infusions. There are 2 major concerns regarding the reliability of the Alaris pump – (1) continued IUI connector problems, and (2) recent recall of pumps when the motor stalls during infusion. Current Status: An interdisciplinary infusion pump steering committee was established. Members include nursing staff from all divisions, pharmacy representatives, clinical engineering- biomed and equipment distribution staff, IT, corporate contracting, anesthesia, and capital equipment repre- sentation. Three vendors were identified (Alaris, Hospira, & Baxter) as having the ability to meet our needs. Vendor demonstrations were held with staff allowing hands on time for individual manipulation of pumps, and an opportunity for questions regarding individual practice areas. The following recommendations were made: There is no interest in piloting the Alaris pump (since the functionality is not different from current pumps). There is an interest to pilot both Hospira Simbiq and the Baxter Sigma Spec- trum. Associated Factors: Other UMMS hospitals are interested in IV pump evaluations. There are varying degrees of readi- ness, but there is some urgency to make a vendor decision by the end of the calendar year. If possible, the UMMS goal is to leverage volume purchases to allow best financial outcome Because UMMC pumps are nearly 10 years old, there is significant cost related to pump repairs and management of IUI issues. Future goal is full electronic integration of pumps from an IT perspective, in- cluding: asset management (pump tracking), wireless library upgrades, Pharmacy communication & E-MAR integration – all of which are potentially available – but require upgrades to our wireless network to support best use of the technology Next Step: Pump Pilot: Two Pilot Trial Options Option 1: Full Clinical Trial on unit for 2 weeks. Units would include: MICU, SICU, Trauma, Acute Care, Pediatrics, Perioperative Areas, Cancer Center. Full library upload required. Option 2: Laboratory Style Clinical Trial where preset scenarios are worked through by nurses. No library upload required. After a decision is made when the pilot is completed, more information will be available on next steps. Baxter Hospira
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
UMMC Nursing Newsletter
September 2012
Volume 1, Issue 8
IV Infusion Pump Update
Background/Situation:
The UMMC contract with Alaris/Carefusion for IV pumps and disposables has expired. UMMC is in
need of additional pumps to accommodate: (1) increased beds in new Shock Trauma tower, and (2) a
general increase in acuity of patients throughout the Medical Center requiring multiple infusions.
There are 2 major concerns regarding the reliability of the Alaris pump – (1) continued IUI connector
problems, and (2) recent recall of pumps when the motor stalls during infusion.
Current Status:
An interdisciplinary infusion pump steering committee was established. Members include nursing
staff from all divisions, pharmacy representatives, clinical engineering- biomed and equipment
distribution staff, IT, corporate contracting, anesthesia, and capital equipment repre-
sentation.
Three vendors were identified (Alaris, Hospira, & Baxter) as having the ability to
meet our needs. Vendor demonstrations were held with staff allowing hands on time
for individual manipulation of pumps, and an opportunity for questions regarding
individual practice areas. The following recommendations were made:
There is no interest in piloting the Alaris pump (since the functionality is not
different from current pumps).
There is an interest to pilot both Hospira Simbiq and the Baxter Sigma Spec-
trum.
Associated Factors:
Other UMMS hospitals are interested in IV pump evaluations. There are varying degrees of readi-
ness, but there is some urgency to make a vendor decision by the end of the calendar year. If possible,
the UMMS goal is to leverage volume purchases to allow best financial outcome
Because UMMC pumps are nearly 10 years old, there is significant cost related
to pump repairs and management of IUI issues.
Future goal is full electronic integration of pumps from an IT perspective, in-